Hematology/Oncology · Voorhees, NJ
NPI
1720082092
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
705 White Horse Rd, Ste D105
Voorhees, NJ, 08043
Phone (856) 435-1777
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
179,016 services
Medicare patients, 2024
636
Average age 75
Drug cost, 2024
$11.4M
2,643 prescriptions
Company payments, 2025
$3,896
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Trina Poretta was code J1439 (injection, ferric carboxymaltose, 1 mg), 117,000 times for 78 patients. In total Trina Poretta billed 179,016 services in 115 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-11-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 117,000 | 78 | $0.87 | $102K |
| J0897 Injection, denosumab, 1 mg | Office | 7,201 | 38 | $20.67 | $149K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 3,483 | 17 | $6.34 | $22K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,457 | 42 | $0.09 | $309 |
| 85025 Blood Count | Office | 1,018 | 325 | $7.58 | $7,714 |
| 99213 Office E&M - Established | Office | 905 | 393 | $68.45 | $62K |
| 36415 Venipuncture Blood Collection | Office | 720 | 295 | $8.63 | $6,211 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 541 | 16 | $0.70 | $378 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 540 | 14 | $0.26 | $142 |
| 99214 Office E&M - Established | Office | 504 | 289 | $102.07 | $51K |
| 96375 Injection Administration | Office | 466 | 50 | $12.89 | $6,008 |
| 96372 Injection Administration | Office | 425 | 115 | $11.84 | $5,031 |
| 96413 Chemotherapy Administration | Office | 256 | 42 | $110.35 | $28K |
| 96365 Intravenous Infusion, Hydration | Office | 196 | 98 | $53.03 | $10K |
| 96401 Chemotherapy Administration | Office | 164 | 11 | $61.03 | $10K |
By year: 2022 $983K for 137,140 services; 2023 $1.3M for 156,190 services; 2024 $1.3M for 179,016 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 1,018 | 325 | $7.58 | $7,714 |
| 36415 Venipuncture Blood Collection | 720 | 295 | $8.63 | $6,211 |
| 80048 Clinical Chemistry | 125 | 43 | $8.18 | $1,022 |
Medicare prescription drug claims, 2024
In 2024, the drug Trina Poretta prescribed most often to Medicare patients was Procrit (Epoetin Alfa), with 115 prescriptions and refills. In total Trina Poretta wrote 2,643 Medicare prescriptions that cost $11.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Procrit Epoetin Alfa | 115 | 115 | 46 | $395K |
| Eliquis Apixaban | 114 | 279 | 37 | $160K |
| Anastrozole Generic | 105 | 313 | 36 | $2,275 |
| Alendronate Sodium Generic | 93 | 247 | 34 | $1,053 |
| Tamoxifen Citrate Generic | 60 | 150 | 14 | $1,089 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 56 | 56 | Under 11 | $610K |
| Imbruvica Ibrutinib | 55 | 55 | Under 11 | $728K |
| Palonosetron Hcl Generic | 53 | 53 | 14 | $1,695 |
| Xgeva Denosumab | 50 | 59 | 12 | $160K |
| Ondansetron Hcl Generic | 49 | 49 | 28 | $371 |
| Hydroxyurea Generic | 47 | 123 | 16 | $1,513 |
| Udenyca Autoinjector Pegfilgrastim-Cbqv | 46 | 46 | 13 | $182K |
| Granisetron Hcl Granisetron Hcl/Pf | 45 | 45 | Under 11 | $582 |
| Ibrance Palbociclib | 45 | 45 | Under 11 | $730K |
| Xarelto Rivaroxaban | 43 | 129 | 15 | $68K |
Brand drugs: 1,361 claims; generic drugs: - claims; opioid claims: 94.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Trina Poretta $3,896 ($3,896 in general payments such as food, travel and fees) from 50 companies. The largest payer was E.R. Squibb & Sons, L.L.C. with $370.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $370 |
| Pfizer Inc. PFE | 15 | $336 |
| Janssen Biotech, Inc. JNJ | 7 | $332 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $295 |
| Gilead Sciences, Inc. GILD | 11 | $190 |
| Stemline Therapeutics Inc. | 6 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 10 | $158 |
| Merck Sharp & Dohme LLC MRK | 6 | $120 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 5 | $103 |
| Daiichi Sankyo Inc. 4568.T | 5 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.